PROTO-HORMONES LEVELS OF ADIPOSE TISSUE, INTERLEUKIN-6 AND INDICATORS OF DETOXIFYING FUNCTION OF THE LIVER IN PATIENTS WITH HYPERTENSION AND OBESITY COMBINED WITH NON-ALCOHOLIC FATTY LIVER DISEASE

PROTO-HORMONES LEVELS OF ADIPOSE TISSUE, INTERLEUKIN-6 AND INDICATORS OF DETOXIFYING FUNCTION OF THE LIVER IN PATIENTS WITH HYPERTENSION AND OBESITY COMBINED WITH NON-ALCOHOLIC FATTY LIVER DISEASE

The research estimates the state of liver detoxifying function and analyzes the changes in the levels of leptin, adiponectin and interleukin-6 in patients with arterial hypertension in combination with obesity and non-alcoholic fatty liver disease. Aim. The aim of the study is to evaluate levels...

Full description

Bibliographic Details
Main Author:	Olesia Bochar
Format:	Article
Language:	English
Published:	Scientific Route OÜ 2020-10-01
Series:	Technology Transfer: Innovative Solutions in Medicine
Subjects:	arterial hypertension, obesity, non-alcoholic steatohepatitis, leptin, adiponectin, il-6, 13c-metacetin breath test.
Online Access:	http://journal.eu-jr.eu/ttism/article/view/1469

Similar Items

Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Gian Paolo Caviglia, et al.
Published: (2021-05-01)

Role of Leptin in Non-Alcoholic Fatty Liver Disease
by: Carlos Jiménez-Cortegana, et al.
Published: (2021-06-01)

De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study
by: Ahmed Abdel-Razik, et al.
Published: (2021-04-01)

The role of adipocytokines in the development of non-alcoholic fatty liver disease in patients with hypertension and obesity
by: Yu.M. Yarynych
Published: (2018-05-01)

The cytokeratin 18, adiponectin and leptin levels in patients with non-alcoholic steatohepatitis and coronary heart disease
by: Oksana S. KHUKHLINA, et al.
Published: (2019-09-01)

Acute Phase Serum Leptin, Adiponectin, Interleukin-6, and Visfatin Are Altered in Chinese Children With Febrile Seizures: A Cross-Sectional Study
by: Jie-ru Chen, et al.
Published: (2020-09-01)

Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer
by: Yetirajam Rajesh, et al.
Published: (2021-02-01)

Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index
by: Stergios A. Polyzos, et al.
Published: (2013-09-01)

Crossing the Antarctica: Exploring the Effects of Appetite-Regulating Hormones and Indicators of Nutrition Status during a 93-Day Solo-Expedition
by: Bjørn Helge Johnsen, et al.
Published: (2021-05-01)

Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis
by: Wim Verlinden, et al.
Published: (2020-11-01)

CLINICOPATHOGENETIC CHARACTERISTICS OF CARDIORENAL SYNDROME IN NON-ALCOHOLIC FATTY DISEASE OF THE LIVER
by: M M Severova, et al.
Published: (2012-06-01)

Peculiarities of biochemical blood parameters and cytokine profile in patients with non-alcoholic fatty liver disease depending on the form of hypothyroidism
by: V.P. Prysyazhnyuk, et al.
Published: (2017-04-01)

Hormones of Adipose Tissue and Gestational Diabetes
by: O.S. Payenok, et al.
Published: (2013-10-01)

Leptin as a Key Player in Insulin Resistance of Liver Cirrhosis? A Cross-Sectional Study in Liver Transplant Candidates
by: Iva Košuta, et al.
Published: (2020-02-01)

Associations of adipocytokine expression and cardiovascular risk factors in stable coronary artery disease
by: E. V. Belik, et al.
Published: (2021-04-01)

Expression of resistin in the liver of patients with non-alcoholic fatty liver disease
by: Piotr Gierej, et al.
Published: (2017-11-01)

Serum adipocytokines and adiposity as predictive indices of preeclampsia
by: Ahmed Tijani Bawah, et al.
Published: (2020-10-01)

Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver disease
by: Mohamed Shoreibah, et al.
Published: (2016-03-01)

Pathophysiology of Non Alcoholic Fatty Liver Disease
by: Salvatore Petta, et al.
Published: (2016-12-01)

Hormonal and adiposity state of women with polycystic ovary syndrome: implication of adiponectin and leptin
by: Aleksandra Atanasova Boshku, et al.
Published: (2016-12-01)

Markers of visceral adipose tissue metabolic abnormalities in patients with coronary atherosclerosis in relation to the presence of type 2 diabetes mellitus
by: N E Gavrilova, et al.
Published: (2015-10-01)

Leptin and interleukin-6 level in patients with hypertension and obesity combined with non-alcoholic steatohepatitis during treatment with sartans and statins
by: Bochar Olesya, et al.
Published: (2017-06-01)

The Relationship between Maternal Plasma Leptin and Adiponectin Concentrations and Newborn Adiposity
by: Natália P. Castro, et al.
Published: (2017-02-01)

Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population
by: Clarisse Noël A. Ayina, et al.
Published: (2017-09-01)

Administration of Bioflavonoides Improves Plasma Levels of Adipocyte Hormones
by: Boncheva M., et al.
Published: (2014-12-01)

Maternal adiposity and plasma concentrations of leptin and adiponectin
by: Ahire, Shwetal
Published: (2009)

Umbilical cord versus maternal serum leptin and adioponectin levels: a comparative study in small and appropriate for gestational age newborns
by: Zakeri HR, et al.
Published: (2009-10-01)

Pro-Inflammatory Diet Is Associated with Adiposity during Childhood and with Adipokines and Inflammatory Markers at 11 Years in Mexican Children
by: Sofia Barragán-Vázquez, et al.
Published: (2020-11-01)

The effects of anthocyanins on body weight and expression of adipocyte’s hormones: Leptin and adiponectin
by: Lada Tucakovic, et al.
Published: (2018-06-01)

The role of leptin in non-alcoholic fatty liver disease
by: Elbadawy Reda, et al.
Published: (2006-01-01)

Dietary Polyphenolsand Non-Alcoholic Fatty Liver Disease
by: Ludovico Abenavoli, et al.
Published: (2021-02-01)

Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Cristiane V. Tovo, et al.
Published: (2019-05-01)

Gender Differences in Adipocyte Metabolism and Liver Cancer Progression
by: Otto Ka-Wing Cheung, et al.
Published: (2016-09-01)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
by: Maria Corina Plaz Torres, et al.
Published: (2020-11-01)

Sexual Dimorphism in the Age-Induced Insulin Resistance, Liver Steatosis, and Adipose Tissue Function in Rats
by: Francisco Garcia-Carrizo, et al.
Published: (2017-07-01)

Adipose Tissue as an Endocrine Organ: An Update on Pro-inflammatory and Anti-inflammatory Microenvironment
by: Kvido Smitka, et al.
Published: (2015-01-01)

Probiotic yogurt improves body mass index and fasting insulin levels without affecting serum leptin and adiponectin levels in non-alcoholic fatty liver disease (NAFLD)
by: Safoora Nabavi, et al.
Published: (2015-10-01)

Human Milk Metabolic Hormones: Analytical Methods and Current Understanding
by: Majed A. Suwaydi, et al.
Published: (2021-08-01)

Pediatric non-alcoholic fatty liver disease
by: Delvin Edgard, et al.
Published: (2015-01-01)

Mimecan, a Hormone Abundantly Expressed in Adipose Tissue, Reduced Food Intake Independently of Leptin Signaling
by: Huang-Ming Cao, et al.
Published: (2015-11-01)